Otrexup - NDC Database

8 records found

Page:1

54436-010 Oct 11, 2013
Otrexup 10 mg/.4ml Subcutaneous Injection, Solution by Antares Pharma, Inc.

54436-012 Oct 11, 2013
Otrexup 12.5 mg/.4ml Subcutaneous Injection, Solution by Antares Pharma, Inc.

54436-015 Oct 11, 2013
Otrexup 15 mg/.4ml Subcutaneous Injection, Solution by Antares Pharma, Inc.

54436-017 Oct 11, 2013
Otrexup 17.5 mg/.4ml Subcutaneous Injection, Solution by Antares Pharma, Inc.

54436-020 Oct 11, 2013
Otrexup 20 mg/.4ml Subcutaneous Injection, Solution by Antares Pharma, Inc.

54436-022 Oct 11, 2013
Otrexup 22.5 mg/.4ml Subcutaneous Injection, Solution by Antares Pharma, Inc.

54436-025 Oct 11, 2013
Otrexup 25 mg/.4ml Subcutaneous Injection, Solution by Antares Pharma, Inc.

54436-075 Oct 11, 2013
Otrexup 7.5 mg/.4ml Subcutaneous Injection, Solution by Antares Pharma, Inc.

Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.